Business · 14/07/2023Updated: 10/17/2026 · 1 min read
FDA Renews National Mammography Quality Assurance Advisory Committee for 2 Years
Summary
The FDA is renewing the National Mammography Quality Assurance Advisory Committee for an additional 2 years, with the new charter set to expire on July 7, 2025, following a determination by the Commissioner of Food and Drugs that it is in the public interest.
Original source language: Federal Register — Food and Drug AdministrationOpen original release →